nodes	percent_of_prediction	percent_of_DWPC	metapath
Metyrapone—ABCC3—Cisplatin—germ cell cancer	0.231	0.238	CbGbCtD
Metyrapone—ABCC3—Etoposide—germ cell cancer	0.227	0.234	CbGbCtD
Metyrapone—CYP2A6—Ifosfamide—germ cell cancer	0.211	0.217	CbGbCtD
Metyrapone—ABCC3—Methotrexate—germ cell cancer	0.15	0.155	CbGbCtD
Metyrapone—CYP2E1—Etoposide—germ cell cancer	0.0666	0.0686	CbGbCtD
Metyrapone—CYP3A4—Ifosfamide—germ cell cancer	0.0422	0.0435	CbGbCtD
Metyrapone—CYP3A4—Vinblastine—germ cell cancer	0.0224	0.0231	CbGbCtD
Metyrapone—CYP3A4—Etoposide—germ cell cancer	0.0202	0.0208	CbGbCtD
Metyrapone—Endocrine disorder—Ifosfamide—germ cell cancer	0.00129	0.0453	CcSEcCtD
Metyrapone—Pancytopenia—Vinblastine—germ cell cancer	0.00088	0.031	CcSEcCtD
Metyrapone—Bone marrow depression—Methotrexate—germ cell cancer	0.000747	0.0263	CcSEcCtD
Metyrapone—Pancytopenia—Bleomycin—germ cell cancer	0.000743	0.0262	CcSEcCtD
Metyrapone—Pancytopenia—Dactinomycin—germ cell cancer	0.000693	0.0244	CcSEcCtD
Metyrapone—Alopecia—Vinblastine—germ cell cancer	0.000655	0.0231	CcSEcCtD
Metyrapone—Pancytopenia—Ifosfamide—germ cell cancer	0.000635	0.0224	CcSEcCtD
Metyrapone—Hypertension—Vinblastine—germ cell cancer	0.000557	0.0196	CcSEcCtD
Metyrapone—Alopecia—Bleomycin—germ cell cancer	0.000553	0.0195	CcSEcCtD
Metyrapone—Abdominal discomfort—Cisplatin—germ cell cancer	0.000553	0.0195	CcSEcCtD
Metyrapone—Pancytopenia—Cisplatin—germ cell cancer	0.000547	0.0193	CcSEcCtD
Metyrapone—Alopecia—Dactinomycin—germ cell cancer	0.000516	0.0182	CcSEcCtD
Metyrapone—Pancytopenia—Etoposide—germ cell cancer	0.000502	0.0177	CcSEcCtD
Metyrapone—Angiopathy—Ifosfamide—germ cell cancer	0.000486	0.0171	CcSEcCtD
Metyrapone—Alopecia—Ifosfamide—germ cell cancer	0.000473	0.0167	CcSEcCtD
Metyrapone—Pain—Vinblastine—germ cell cancer	0.00045	0.0159	CcSEcCtD
Metyrapone—Gastrointestinal pain—Vinblastine—germ cell cancer	0.000431	0.0152	CcSEcCtD
Metyrapone—Abdominal pain—Vinblastine—germ cell cancer	0.000416	0.0147	CcSEcCtD
Metyrapone—Hypotension—Bleomycin—germ cell cancer	0.000416	0.0146	CcSEcCtD
Metyrapone—Alopecia—Cisplatin—germ cell cancer	0.000408	0.0144	CcSEcCtD
Metyrapone—Hypertension—Ifosfamide—germ cell cancer	0.000402	0.0142	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000394	0.0139	CcSEcCtD
Metyrapone—Angiopathy—Etoposide—germ cell cancer	0.000384	0.0135	CcSEcCtD
Metyrapone—Pain—Bleomycin—germ cell cancer	0.00038	0.0134	CcSEcCtD
Metyrapone—Alopecia—Etoposide—germ cell cancer	0.000374	0.0132	CcSEcCtD
Metyrapone—Nervous system disorder—Ifosfamide—germ cell cancer	0.000373	0.0131	CcSEcCtD
Metyrapone—Skin disorder—Ifosfamide—germ cell cancer	0.000369	0.013	CcSEcCtD
Metyrapone—Hypotension—Ifosfamide—germ cell cancer	0.000355	0.0125	CcSEcCtD
Metyrapone—Pain—Dactinomycin—germ cell cancer	0.000355	0.0125	CcSEcCtD
Metyrapone—Dizziness—Vinblastine—germ cell cancer	0.000348	0.0123	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00034	0.012	CcSEcCtD
Metyrapone—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000339	0.012	CcSEcCtD
Metyrapone—Vomiting—Vinblastine—germ cell cancer	0.000335	0.0118	CcSEcCtD
Metyrapone—Headache—Vinblastine—germ cell cancer	0.00033	0.0116	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000328	0.0116	CcSEcCtD
Metyrapone—Abdominal pain—Dactinomycin—germ cell cancer	0.000328	0.0116	CcSEcCtD
Metyrapone—Pain—Ifosfamide—germ cell cancer	0.000325	0.0115	CcSEcCtD
Metyrapone—Nervous system disorder—Cisplatin—germ cell cancer	0.000321	0.0113	CcSEcCtD
Metyrapone—Skin disorder—Cisplatin—germ cell cancer	0.000318	0.0112	CcSEcCtD
Metyrapone—Hypertension—Etoposide—germ cell cancer	0.000318	0.0112	CcSEcCtD
Metyrapone—Nausea—Vinblastine—germ cell cancer	0.000313	0.011	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000311	0.011	CcSEcCtD
Metyrapone—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000311	0.011	CcSEcCtD
Metyrapone—Hypotension—Cisplatin—germ cell cancer	0.000306	0.0108	CcSEcCtD
Metyrapone—Abdominal discomfort—Methotrexate—germ cell cancer	0.000303	0.0107	CcSEcCtD
Metyrapone—Abdominal pain—Ifosfamide—germ cell cancer	0.000301	0.0106	CcSEcCtD
Metyrapone—Pancytopenia—Methotrexate—germ cell cancer	0.0003	0.0106	CcSEcCtD
Metyrapone—Skin disorder—Etoposide—germ cell cancer	0.000292	0.0103	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000283	0.00997	CcSEcCtD
Metyrapone—Vomiting—Bleomycin—germ cell cancer	0.000283	0.00996	CcSEcCtD
Metyrapone—Hypotension—Etoposide—germ cell cancer	0.000281	0.00988	CcSEcCtD
Metyrapone—Pain—Cisplatin—germ cell cancer	0.00028	0.00987	CcSEcCtD
Metyrapone—Nausea—Bleomycin—germ cell cancer	0.000264	0.00931	CcSEcCtD
Metyrapone—Vomiting—Dactinomycin—germ cell cancer	0.000264	0.00929	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000259	0.00913	CcSEcCtD
Metyrapone—Pain—Etoposide—germ cell cancer	0.000257	0.00905	CcSEcCtD
Metyrapone—Dizziness—Ifosfamide—germ cell cancer	0.000251	0.00886	CcSEcCtD
Metyrapone—Nausea—Dactinomycin—germ cell cancer	0.000246	0.00868	CcSEcCtD
Metyrapone—Gastrointestinal pain—Etoposide—germ cell cancer	0.000246	0.00865	CcSEcCtD
Metyrapone—Vomiting—Ifosfamide—germ cell cancer	0.000242	0.00852	CcSEcCtD
Metyrapone—Abdominal pain—Etoposide—germ cell cancer	0.000237	0.00836	CcSEcCtD
Metyrapone—Angiopathy—Methotrexate—germ cell cancer	0.00023	0.00809	CcSEcCtD
Metyrapone—Nausea—Ifosfamide—germ cell cancer	0.000226	0.00796	CcSEcCtD
Metyrapone—Alopecia—Methotrexate—germ cell cancer	0.000224	0.00788	CcSEcCtD
Metyrapone—Vomiting—Cisplatin—germ cell cancer	0.000208	0.00734	CcSEcCtD
Metyrapone—Dizziness—Etoposide—germ cell cancer	0.000199	0.007	CcSEcCtD
Metyrapone—Nausea—Cisplatin—germ cell cancer	0.000195	0.00686	CcSEcCtD
Metyrapone—Vomiting—Etoposide—germ cell cancer	0.000191	0.00673	CcSEcCtD
Metyrapone—Headache—Etoposide—germ cell cancer	0.000188	0.00663	CcSEcCtD
Metyrapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000186	0.00656	CcSEcCtD
Metyrapone—Nausea—Etoposide—germ cell cancer	0.000178	0.00628	CcSEcCtD
Metyrapone—Nervous system disorder—Methotrexate—germ cell cancer	0.000176	0.00621	CcSEcCtD
Metyrapone—Skin disorder—Methotrexate—germ cell cancer	0.000175	0.00615	CcSEcCtD
Metyrapone—Hypotension—Methotrexate—germ cell cancer	0.000168	0.00592	CcSEcCtD
Metyrapone—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000155	0.00547	CcSEcCtD
Metyrapone—Pain—Methotrexate—germ cell cancer	0.000154	0.00542	CcSEcCtD
Metyrapone—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000147	0.00518	CcSEcCtD
Metyrapone—Abdominal pain—Methotrexate—germ cell cancer	0.000142	0.00501	CcSEcCtD
Metyrapone—Dizziness—Methotrexate—germ cell cancer	0.000119	0.00419	CcSEcCtD
Metyrapone—Vomiting—Methotrexate—germ cell cancer	0.000114	0.00403	CcSEcCtD
Metyrapone—Headache—Methotrexate—germ cell cancer	0.000113	0.00397	CcSEcCtD
Metyrapone—Nausea—Methotrexate—germ cell cancer	0.000107	0.00376	CcSEcCtD
